Related content

Chairman of the Joint Formulary Committee, British National Formulary

By Kendall Martin  

Clinical Medicine, Vol. 9, Iss. 4, 2009-08 ,pp. : 349-352

Royal College Of Physicians

Access to resources Recommend Favorite

Drug Interactions with Cholinesterase Inhibitors: An Analysis of the French Pharmacovigilance Database and a Comparison of Two National Drug Formularies (Vidal, British National Formulary)

By Tavassoli Neda   Sommet Agnes   Lapeyre-Mestre Maryse   Bagheri Haleh   Montrastruc Jean-Louis  

Drug Safety, Vol. 30, Iss. 11, 2007-01 ,pp. : 1063-1071

Adis International

Access to resources Recommend Favorite

The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary: Cost-Effectiveness and Budget-Impact Analyses

By Machado Márcio   Iskedjian Michael  

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 979-990

Adis International

Access to resources Recommend Favorite

Italy's reimbursement list to become national formulary

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 250, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Applying cognitive policy analysis to the drug issue: Harm reduction and the reversal of the deviantization of drug users in Britain 1985–1997

By Hudebine Hervé  

Addiction Research and Theory, Vol. 13, Iss. 3, 2005-06 ,pp. : 231-243

Informa Healthcare

Access to resources Recommend Favorite